Caracterización fenotípica de animales modificados genéticamente
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Consequences of telomere dysfunction in fibroblasts, club and basal cells for lung fibrosis development
Nature Communications, Vol. 13, Núm. 1